Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston Scientific
MedTech
Boston Scientific claims EU approval for Farapoint PFA catheter
The CE Mark adds the treatment of right atrial flutter to the company’s burgeoning Farapulse platform for irregular heart rhythms.
Conor Hale
Dec 2, 2025 12:28pm
Acquisitive Boston Scientific sees growth rate ease in Q3
Oct 22, 2025 10:05am
Boston Scientific to drop $533M to acquire Nalu Medical
Oct 20, 2025 12:04pm
FDA updates recall for Boston Scientific implanted defib leads
Sep 15, 2025 11:55am
The highest-paid medtech CEOs of 2024
Jul 28, 2025 6:00am
Boston Scientific bumps financial forecasts amid device gains
Jul 23, 2025 10:32am
